Protein Kinase Inhibitors as a Therapeutic Modality-Reference-Cited by-同舟云学术

Protein Kinase Inhibitors as a Therapeutic Modality

Published:2003-05-29 Issue:6 Volume:36 Page:462-469
ISSN:0001-4842
Container-title:Accounts of Chemical Research
language:en
Short-container-title:Acc. Chem. Res.

Author:

Levitzki Alexander¹

Affiliation:

1. Unit of Cellular Signaling, Department of Biological Chemistry, The Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem 91904, Israel

Publisher

American Chemical Society (ACS)

Subject

General Medicine,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/ar0201207

Reference84 articles.

1. Tyrphostins as molecular tools and potential antiproliferative drugs

2. Signal-Transduction Therapy. A Novel Approach to Disease Management

3. Signal Transduction Interception as a Novel Approach to Disease Management

4. Tyrphostins—Potential antiproliferative agents and novel molecular tools

5. Tyrphostins: tyrosine kinase blockers as novel antiproliferative agents and dissectors of signal transduction

Cited by 171 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kinase inhibitors: 20 years of success and many new challenges and recent trends in their patents;Expert Opinion on Therapeutic Patents;2024-05-24

2. Spirooxindole derivatives as kinase-based anticancer agents;Spirooxindole;2024

3. Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies;Signal Transduction and Targeted Therapy;2023-12-18

4. Artificial intelligence methods in kinase target profiling: Advances and challenges;Drug Discovery Today;2023-11

5. Large-Scale Modeling of Sparse Protein Kinase Activity Data;Journal of Chemical Information and Modeling;2023-06-09